PriceTargets.com logo

Nova - NVMI Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $514.44
  • Forecasted Upside: 22.26%
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 8 Buy Ratings
  • 1 Strong Buy Ratings
$420.79 As of 08/17/2026 05:00 PM ET
▲ +2.67 (0.64%)

This chart shows the closing price for NVMI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Nova Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NVMI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NVMI

Analyst Price Target is $514.44
▲ +22.26% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Nova in the last 3 months. The average price target is $514.44, with a high forecast of $600.00 and a low forecast of $345.00. The average price target represents a 22.26% upside from the last price of $420.79.

This chart shows the closing price for NVMI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 11 polled investment analysts is to moderate buy stock in Nova. This rating has held steady since March 2026, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/22/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/23/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/21/2025
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/19/2025
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/17/2026
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/18/2026
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
7/17/2026
  • 1 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
8/16/2026

Latest Recommendations

  • 1 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/10/2026CitigroupLower TargetBuy ➝ Buy$595.00 ➝ $550.00
8/7/2026EvercoreSet Target$475.00
8/7/2026Zacks ResearchUpgradeHold ➝ Strong-Buy
8/7/2026Needham & Company LLCLower TargetBuy ➝ Buy$640.00 ➝ $570.00
8/7/2026Cantor FitzgeraldLower TargetOverweight ➝ Overweight$600.00 ➝ $500.00
8/6/2026Jefferies Financial GroupReiterated RatingBuy ➝ Buy$600.00
7/14/2026Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$600.00
7/7/2026Weiss RatingsDowngradeHold (C+) ➝ Hold (C)
7/6/2026Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$494.00 ➝ $540.00
5/15/2026EvercoreReiterated RatingOutperform ➝ Outperform$600.00
5/15/2026CitigroupBoost TargetBuy ➝ Buy$520.00 ➝ $595.00
5/15/2026BarclaysBoost TargetOverweight ➝ Overweight$465.00 ➝ $600.00
5/14/2026Jefferies Financial GroupBoost TargetBuy ➝ Buy$520.00 ➝ $640.00
5/14/2026Weiss RatingsUpgradeHold (C) ➝ Hold (C+)
5/14/2026Morgan StanleySet Target$494.00
5/14/2026Needham & Company LLCBoost TargetBuy ➝ Buy$500.00 ➝ $640.00
4/14/2026Zacks ResearchDowngradeStrong-Buy ➝ Hold
4/10/2026Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
3/11/2026BarclaysInitiated CoverageOverweight$465.00
2/20/2026Zacks ResearchUpgradeHold ➝ Strong-Buy
2/13/2026Morgan StanleyReiterated RatingOutperform ➝ Outperform$453.00
2/13/2026CitigroupBoost TargetBuy ➝ Buy$370.00 ➝ $520.00
2/13/2026EvercoreReiterated RatingOutperform ➝ Outperform$485.00
2/12/2026Jefferies Financial GroupReiterated RatingBuy ➝ Buy$520.00
1/13/2026Bank of AmericaBoost TargetBuy ➝ Buy$380.00 ➝ $450.00
12/22/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
12/15/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
12/15/2025Jefferies Financial GroupBoost TargetBuy ➝ Buy$360.00 ➝ $390.00
12/1/2025Morgan StanleyInitiated CoverageEqual Weight$335.00
12/1/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
11/24/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
11/7/2025BenchmarkBoost TargetBuy ➝ Buy$280.00 ➝ $345.00
11/7/2025EvercoreBoost TargetOutperform ➝ Outperform$290.00 ➝ $340.00
10/8/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
9/27/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
6/24/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$250.00 ➝ $300.00
6/24/2025Bank of AmericaBoost TargetBuy ➝ Buy$250.00 ➝ $270.00
5/9/2025CitigroupLower TargetBuy ➝ Buy$290.00 ➝ $280.00
5/9/2025BenchmarkLower TargetBuy ➝ Buy$295.00 ➝ $280.00
4/16/2025Bank of AmericaLower TargetBuy ➝ Buy$310.00 ➝ $248.00
3/14/2025Cantor FitzgeraldLower TargetOverweight ➝ Overweight$315.00 ➝ $300.00
2/14/2025BenchmarkBoost TargetBuy ➝ Buy$245.00 ➝ $295.00
2/14/2025Needham & Company LLCReiterated RatingHold ➝ Hold
1/13/2025Cantor FitzgeraldInitiated CoverageOverweight$275.00
1/6/2025CitigroupUpgradeNeutral ➝ Buy$226.00 ➝ $240.00
11/8/2024BenchmarkBoost TargetBuy ➝ Buy$240.00 ➝ $245.00
11/8/2024Needham & Company LLCReiterated RatingHold
9/16/2024CitigroupDowngradeBuy ➝ Neutral$273.00 ➝ $224.00
8/9/2024BenchmarkBoost TargetBuy ➝ Buy$215.00 ➝ $240.00
7/15/2024CitigroupBoost TargetBuy ➝ Buy$223.00 ➝ $273.00
5/13/2024Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$200.00 ➝ $240.00
5/10/2024BenchmarkBoost TargetBuy ➝ Buy$187.00 ➝ $215.00
5/10/2024Needham & Company LLCReiterated RatingHold
5/10/2024Bank of AmericaBoost TargetBuy ➝ Buy$190.00 ➝ $220.00
4/16/2024EvercoreInitiated CoverageOutperform$210.00
2/16/2024BenchmarkBoost TargetBuy ➝ Buy$150.00 ➝ $187.00
12/28/2023BenchmarkBoost TargetBuy ➝ Buy$125.00 ➝ $150.00
11/10/2023BenchmarkLower TargetBuy ➝ Buy$135.00 ➝ $125.00
8/4/2023BenchmarkBoost TargetBuy ➝ Buy$106.00 ➝ $135.00
6/14/2023Needham & Company LLCDowngradeBuy ➝ Hold
4/20/2023Jefferies Financial GroupInitiated CoverageBuy$115.00
2/16/2023BenchmarkBoost TargetBuy$100.00 ➝ $106.00
2/14/2023Needham & Company LLCBoost TargetBuy$90.00 ➝ $110.00
11/13/2022CitigroupLower Target$123.00
11/4/2022Needham & Company LLCBoost TargetBuy$85.00 ➝ $90.00
10/7/2022Bank of AmericaLower TargetBuy$130.00 ➝ $107.00
8/9/2022BenchmarkLower Target$146.00 ➝ $140.00
6/29/2022Bank of AmericaLower TargetBuy$140.00 ➝ $115.00
2/25/2022CitigroupLower TargetBuy$146.00 ➝ $142.00
2/25/2022Needham & Company LLCLower TargetBuy$150.00 ➝ $130.00
1/10/2022Bank of AmericaBoost TargetBuy$150.00 ➝ $160.00
11/17/2021Needham & Company LLCBoost TargetPositive ➝ Buy$135.00 ➝ $150.00
11/17/2021BenchmarkBoost TargetBuy$136.00 ➝ $146.00
11/5/2021Needham & Company LLCBoost TargetBuy$110.00 ➝ $135.00
9/17/2021Bank of AmericaBoost TargetBuy$120.00 ➝ $125.00
9/17/2021BarclaysBoost TargetTop Pick ➝ Overweight$120.00 ➝ $125.00
(Data available from 8/17/2021 forward)

News Sentiment Rating

1.06 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/19/2026
  • 3 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
2/18/2026
  • 3 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2026
  • 4 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2026
  • 6 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/19/2026
  • 4 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/18/2026
  • 7 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/18/2026
  • 26 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
8/17/2026

Current Sentiment

  • 26 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Nova logo
Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging. The company serves various sectors of the integrated circuit manufacturing industry, including logic, foundries, and memory manufacturers, as well as process equipment manufacturers. Nova Ltd. was formerly known as Nova Measuring Instruments Ltd. and changed its name to Nova Ltd. in July 2021. Nova Ltd. was incorporated in 1993 and is headquartered in Rehovot, Israel.
Read More

Today's Range

Now: $420.79
Low: $415.55
High: $431.58

50 Day Range

MA: $470.27
Low: $366.91
High: $605.65

52 Week Range

Now: $420.79
Low: $232.73
High: $615.99

Volume

374,118 shs

Average Volume

443,288 shs

Market Capitalization

$13.37 billion

P/E Ratio

52.08

Dividend Yield

N/A

Beta

1.78

Frequently Asked Questions

What sell-side analysts currently cover shares of Nova?

The following Wall Street analysts have issued stock ratings on Nova in the last twelve months: Bank of America Corporation, Barclays PLC, Benchmark Co., Cantor Fitzgerald, Citigroup Inc., Evercore Inc, Jefferies Financial Group Inc., Morgan Stanley, Needham & Company LLC, Wall Street Zen, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for NVMI.

What is the current price target for Nova?

0 Wall Street analysts have set twelve-month price targets for Nova in the last year. Their average twelve-month price target is $514.44, suggesting a possible upside of 19.9%. Barclays PLC has the highest price target set, predicting NVMI will reach $600.00 in the next twelve months. Benchmark Co. has the lowest price target set, forecasting a price of $345.00 for Nova in the next year.
View the latest price targets for NVMI.

What is the current consensus analyst rating for Nova?

Nova currently has 2 hold ratings, 8 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for NVMI.

What other companies compete with Nova?

Other companies that are similar to Nova include Advanced Energy Industries, Applied Materials, Camtek, Entegris and FormFactor. Learn More about companies similar to Nova.

How do I contact Nova's investor relations team?

Nova's physical mailing address is 5 DAVID FIKES STREET P.O. BOX 266, REHOVOT L3, 7610201. The semiconductor company's listed phone number is 972732295600 and its investor relations email address is [email protected]. The official website for Nova is www.novami.com. Learn More about contacing Nova investor relations.